Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS5346981 A
Publication typeGrant
Application numberUS 08/003,755
Publication dateSep 13, 1994
Filing dateJan 13, 1993
Priority dateJan 13, 1993
Fee statusPaid
Also published asCA2111155A1, DE69409409D1, DE69409409T2, EP0606832A2, EP0606832A3, EP0606832B1
Publication number003755, 08003755, US 5346981 A, US 5346981A, US-A-5346981, US5346981 A, US5346981A
InventorsAshok M. Sarpeshkar, Peter H. Markusch
Original AssigneeMiles Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Brominated chain extender
US 5346981 A
Abstract
This invention relates to radiopaque polyurethane compositions that are reaction products of
(a) cycloaliphatic diisocyanates;
(b) at least one polyester, polycarbonate, and/or polyester carbonate diol having a molecular weight of from about 1000 to about 6000;
(c) an isocyanate-reactive bromine-containing aromatic chain extender; and
(d) optionally, a catalyst;
wherein the quantity of component (c) is such that the amount of bromine in the polyurethane composition is from 10 to 35% by weight, and wherein the components are reacted at an isocyanate index of from 0.95 to 1.2.
Images(6)
Previous page
Next page
Claims(8)
What is claimed:
1. An optically clear radiopaque polyurethane composition comprising a reaction product of
(a) a cycloaliphatic diisocyanate;
(b) at least one polyester diol having a molecular weight of from about 1000 to about 6000;
(c) an isocyanate-reactive bromine-containing aromatic chain extender; and
(d) optionally, a catalyst;
wherein the quantity of component (c) is such that the amount of bromine in the polyurethane composition is from 20 to 30% by weight, and wherein the components are reacted at an isocyanate index of from 0.95 to 1.2.
2. An optically clear, radiopaque polyurethane composition according to claim 1 wherein the cycloaliphatic diisocyanate is dicyclohexylmethane-4,4'-diisocyanate.
3. An optically clear, radiopaque polyurethane composition according to claim 1 wherein component (b) is a polyester diol consisting of a condensation product of adipic acid and a C4 -C8 alkanediol.
4. An optically clear, radiopaque polyurethane composition according to claim 1 wherein component (b) is a polyester diol having a molecular weight of from 2000 to 4000.
5. An optically clear, radiopaque polyurethane composition according to claim 1 wherein component (b) is a polyester diol consisting of a polybutylene adipate having a molecular weight of from 2000 to 4000.
6. An optically clear, radiopaque polyurethane composition according to claim 1 wherein the isocyanate-reactive bromine-containing aromatic chain extender is tetrabromobisphenol A bis(2-hydroxyethyl ether).
7. An optically clear, radiopaque polyurethane composition comprising a reaction product of
(a) dicyclohexylmethane-4,4'-diisocyanate;
(b) a polybutylene adipate having a molecular weight of from 2000 to 4000;
(c) tetrabromobisphenol A bis(2-hydroxyethyl ether) as chain extender; and
(d) optionally, a catalyst;
wherein the quantity of component (c) is such that the amount of bromine in the polyurethane composition is from 20 to 30% by weight, and wherein the components are reacted at an isocyanate index of from 0.95 to 1.2.
8. An optically clear, radiopaque polyurethane composition according to claim 1 prepared by melt processing.
Description
BACKGROUND OF THE INVENTION

This invention relates to radiopaque polyurethane compositions having a bromine content of from 10 to 35% by weight prepared by the reaction of cycloaliphatic diisocyanates, certain polyester diols, and a sufficient amount of a bromine-containing aromatic chain extender to provide the required bromine content.

When medical or veterinary devices are inserted or implanted in a subject, it is often desirable to be able to locate them by X-ray examination, particularly when catheters or cannulas are being inserted into body cavities, passages, or vessels. It is also often desirable, especially with catheters, to observe visually fluids within exposed portions of such devices.

Consequently, an object of the present invention is to prepare radiopaque polyurethane compositions that are preferably optically transparent.

Several approaches for achieving this object in catheters have been reported. For example, U.S. Pat. No. 2,212,334 discloses the incorporation of short segments of radiopaque material within otherwise transparent tubes by introduction of such material at regular intervals during manufacture of the catheters. Alternatively, U.S. Pat. Nos. 2,857,915, 4,027,659, and 4,105,732 disclose the introduction of the radiopaque material as continuous stripes running the length of the catheters. It is also possible to include a radiopaque material only at the distal end of the catheter, as disclosed in U.S. Pat. No. 3,605,750, but the intervening portion of the catheter is not readily detectable by X-ray examination. Similarly, U.S. Pat. No. 3,529,633 discloses catheters made primarily from polymers that are opaque to both X-rays and visible light but also have small sections made from transparent materials.

Another variant of this approach is described in U.S. Pat. No. 3,618,614, which discloses a multiwall tubing having a thick transparent inner tube encased within a thin transparent tube containing a radiopaque material. In this variant, the relatively longer path-length through edges of the tube provides sufficient contrast to appear during X-ray examination. U.S. Pat. No. 3,336,918 discloses similar effects obtained by incorporating metal powders into polyurethane coatings.

Yet another approach is to disperse X-ray opaque substances, such as barium sulfate, a bismuth halide, or a halogen-containing plasticizer, diol, or other such halogen-containing material, throughout a visually transparent polymer. See, for example, Y. Delaviz et al., Polymer Preprints (Polymer Division, Am. Chem. Soc.), 30, 215-216 (1989), and U.S. Pat. Nos. 3,608,555, 3,645,955, 3,749,134, 3,901,829, and 4,282,876. Blends of polymers, at least one of which is radiopaque, are reported, for example, in U.S. Pat. No. 4,182,787, to provide similar effects. Each of these approaches, however, involves the use of physical blends, at least some of which have inherent disadvantages. For example, some of the radiopaque substances can be leached out of the polymeric substrate and absorbed by the body. In addition, some additives can have other incompatibilities that make them unsuitable for use in humans or animals.

It would be particularly advantageous to make the medical or veterinary devices from a polymeric material in which the radiopaque component is incorporated as a structural unit of the polymer. For example, U.S. Pat. No. 4,722,344, which is incorporated by reference, discloses polyurethanes prepared using halogenated polyols and/or halogenated polyisocyanates as reactants. Although the polyurethanes disclosed in U.S. Pat. No. 4,722,344 incorporate sufficient bromine to provide the desired radiopacity, these polyurethanes have a high flex modulus but do not exhibit the desirable softening effect in saline solutions (which are used in testing as a substitute for blood).

Optically transparent radiopaque polyurethanes that are dimensionally stable under standard sterilization conditions (for example, ethylene oxide treatment or gamma irradiation) would be desirable. This stability can be achieved by using crystalline building blocks. For example, polyester diols based on adipic acid and C4 -C8 alkanediols can provide elastomers having enhanced crystallinity. Aromatic chain extenders can further enhance polymer crystallinity. It is possible to make radiopaque polyurethanes based on cycloaliphatic diisocyanates, polyester diols, and isocyanate-reactive bromine-containing compounds, but polyester-polyurethanes of this type that are both radiopaque and optically transparent have not previously been reported.

Soft optically transparent radiopaque polyurethanes have been disclosed in U.S. Pat. No. 5,177,170 but the disclosed polyurethanes are based on polyethers and certain aliphatic bromine-containing chain extenders rather than on the polyester and/or polycarbonate polyols and aromatic bromine-containing chain extenders of the present invention.

It was, therefore, an object of the present invention to obtain radiopaque polyurethanes (preferably optically transparent polyurethanes) having high halogen content that are normally hard and elastic but which soften upon exposure to blood or saline solutions. This object has been accomplished by using polyols containing ester and/or carbonate groups and partially or completely replacing the previously reported brominated chain extenders with isocyanate-reactive bromine-containing aromatic chain extenders such as tetrabromobisphenol A bis(2-hydroxyethyl ether).

SUMMARY OF THE INVENTION

This invention relates to a radiopaque polyurethane composition comprising a reaction product of

(a) a cycloaliphatic diisocyanate;

(b) at least one polyester, polycarbonate, and/or polyester carbonate diol having a molecular weight of from about 1000 to about 6000;

(c) an isocyanate-reactive bromine-containing aromatic chain extender (preferably tetrabromobisphenol A bis(2-hydroxyethyl ether)); and

(d) optionally, a catalyst;

wherein the quantity of component (c) is such that the amount of bromine in the polyurethane composition is from about 10 to about 35% by weight (preferably from 20 to 30% by weight), and wherein the components are reacted at an isocyanate index of from about 0.95 to about 1.2.

DETAILED DESCRIPTION OF THE INVENTION

Suitable diisocyanates for preparing the polyurethane compositions of the invention are those containing one or more cycloaliphatic hydrocarbon groups containing 4 to about 15 (preferably 5 to 10) carbon atoms. Examples of suitable such cycloaliphatic diisocyanates include cyclobutane-1,3-diisocyanate, cyclohexane-1,3- and -1,4-diisocyanate and mixtures thereof, 1-isocyanato-3,3,5-trimethyl-5-isocyanatomethylcyclohexane (isophorone diisocyanate), 2,4- and 2,6-hexahydrotoluene diisocyanate and mixtures thereof, and dicyclohexylmethane-4,4'-diisocyanate ("hydrogenated MDI", or "HMDI"). Dicyclohexylmethane-4,4'-diisocyanate is particularly preferred.

Suitable hydroxyl-containing polyesters include reaction products of polyhydric alcohols (preferably diols), optionally with the addition of trihydric alcohols, and polybasic (preferably dibasic) carboxylic acids and have a molecular weight of from about 1000 to about 6000. Instead of free polycarboxylic acids, the corresponding polycarboxylic acid anhydrides or corresponding polycarboxylic acid esters of lower alcohols or mixtures thereof may be used for preparing the polyesters. The polycarboxylic acids may be aliphatic, cycloaliphatic, aromatic, or heterocyclic and may be substituted, e.g., by halogen atoms, and/or unsaturated. Suitable polycarboxylic acids include succinic acid, adipic acid, suberic acid, azelaic acid, sebacic acid, phthalic acid, isophthalic acid, trimellitic acid, phthalic acid anhydride, tetrahydrophthalic acid anhydride, hexahydrophthalic acid anhydride, tetrachlorophthalic acid anhydride, endo-methylene tetrahydrophthalic acid anhydride, glutaric acid anhydride, maleic acid, maleic acid anhydride, fumaric acid, dimeric and trimeric fatty acids, dimethyl terephthalic, and terephthalic acid bis-glycol esters. Suitable polyhydric alcohols include ethylene glycol, 1,2- and 1,3-propanediol, 1,4- and 2,3-butanediol, 1,6-hexanediol, 1,8-octanediol, neopentyl glycol, 1,3-and 1,4-bis(hydroxymethyl)cyclohexane, 2-methyl-1,3-propanediol, glycerol, trimethylolpropane, 1,2,6-hexanetriol, 1,2,4-butanetriol, trimethylolethane, pentaerythritol, quinitol, mannitol, sorbitol, methyl glycoside, diethylene glycol, triethylene glycol, tetraethylene glycol, polyethylene glycols, dipropylene glycol, polypropylene glycols, dibutylene glycol, and polybutylene glycols. The polyesters may also contain a proportion of carboxyl end groups. Polyesters of lactones, such as ε-caprolactone, or of hydroxycarboxylic acids, such as ω-hydroxycaproic acid, may also be used. Hydrolytically stable polyesters are preferably used in order to obtain the greatest benefit relative to the hydrolytic stability of the final product. Preferred polyesters include polyesters of adipic acid and straight chained or branched C4 -C8 diols, most preferably a polybutylene adipate having a molecular weight of from 2000 to 4000.

Suitable polycarbonates include those prepared by the reaction of diols, such as 1,3-propanediol, 1,4-butanediol, 1,6-hexanediol, diethylene glycol, triethylene glycol, tetraethylene glycol, or thiodiglycol, with phosgene or diaryl carbonates such as diphenyl carbonate. E.g., German Auslegeschriften 1,694,080, 1,915,908, and 2,221,751; German Offenlegungsschrift 2,605,024.

Suitable polyester carbonates include those prepared by the reaction of polyester diols, with or without other diols such as 1,3-propanediol, 1,4-butanediol, 1,6-hexanediol, diethylene glycol, triethylene glycol, tetraethylene glycol, or thiodiglycol, with phosgene, cyclic carbonates, or diaryl carbonates such as diphenyl carbonate. Suitable polyester carbonates more generally include compounds such as those disclosed in U.S. Pat. No. 4,430,484.

Any mixtures of the above-mentioned polyesters, polycarbonates, and polyester carbonates are, of course, also suitable.

The brominated chain extender is an isocyanate-reactive bromine-containing aromatic chain extender, including, for example, compounds having the formulas ##STR1##

Each of the illustrative bromine-containing chain extenders is available commercially or can be prepared by methods known in the art. It is also possible, although not preferred, to use other brominated chain extenders known in the art. A preferred chain extender is tetrabromobisphenol A bis(2-hydroxyethyl ether) (that is, the chain extender of formula (I)), which is available commercially from Great Lakes Chemical Corporation. See also E. R. Larsen, "Halogenated Flame Retardants" in Kirk-Othmer Encyclopedia of Chemical Technology, Third Edition, Vol. 10 (New York: John Wiley & Sons, 1980), pages 373-395. A mixture containing more than one brominated chain extender can, of course, be used.

The brominated chain extender is used in a quantity such that the amount of bromine is sufficient to render the polyurethane radiopaque. The term "radiopaque" refers to the property of polyurethane compositions of the invention that allows articles prepared from such compositions to be detected by customary X-ray examination procedures after insertion into the patient. It has been found that a bromine content of at least about 10 to 15% by weight of polyurethane is generally sufficient to provide radiopacity. In addition to exhibiting excellent radiopacity, the preferred polyurethane compositions of the invention are optically transparent. The term "optically transparent" refers to the property of polyurethane compositions of the invention that allows normal visual observation into or through articles prepared from such compositions. For example, blood or other fluids contained in flowing through an optically transparent catheter can be observed from outside the catheter under normal illumination. Although a bromine content of at least about 10 to 15% by weight is sufficient to confer radiopacity, it has been found that a bromine content of less than about 20% by weight (depending on the particular brominated chain extender used) may result in an optically opaque or translucent polyurethane.

The specified bromine content of 10 to 35% by weight can be obtained by using the polyester diol component (b) and the brominated chain extender component (c) in quantities such that the weight ratio of the polyether diol to the brominated chain extender is from about 2:98 to about 76:24. The corresponding weight ratio for the preferred range of 20 to 30% by weight bromine is about 19:81 to about 50:50.

Suitable catalysts can be any of the catalysts normally used for the preparation of polyurethanes. Preferred catalysts include the organic metal compounds, especially organic tin compounds. Suitable organic tin compounds include those containing sulfur, such as dioctyl tin mercaptide (German Auslegeschrift 1,769,367 and U.S. Pat. No. 3,645,927), and, preferably, tin(II) salts of carboxylic acids, such as tin(II) acetate, tin (II) octoate, tin(II) ethylhexoate, and tin(II) laurate, as well as tin(IV) compounds, such as dibutyltin dilaurate.

Suitable but less preferred catalysts include tertiary amines such as triethylamine, tributylamine, N-methylmorpholine, N-ethylmorpholine, N,N,N',N'-tetramethylethylene diamine, pentamethyldiethylene triamine, and higher homologs (German Offenlegungsschriften 2,624,527 and 2,624,528), 1,4-diazabicyclo[2.2.2]octane, N-methyl-N'-(dimethylaminoethyl)piperazine, bis(dimethylaminoalkyl)piperazines (German Offenlegungsschrift 2,636,787), N,N-dimethylbenzylamine, N,N-dimethylcyclohexylamine, N,N-diethylbenzylamine, bis(N,N-diethylaminoethyl) adipate, N,N,N',N'-tetramethyl-1,3-butanediamine, N,N-dimethyl-β-phenylethylamine, 1,2-dimethylimidazole, 2-methylimidazole, monocyclic and bicyclic amidines (German Offenlegungsschrift 1,720,633), bis(dialkylamino)alkyl ethers (U.S. Pat. No. 3,330,782, German Auslegeschrift 030,558, and German Offenlegungsschriften 1,804,361 and 2,618,280), and tertiary amines containing amide groups (preferably formamide groups) according to German Offenlegungsschriften 2,523,633 and 2,732,292. The catalysts used may also be the known Mannich bases of secondary amines (such as dimethylamine) and aldehydes (preferably formaldehyde) or ketones (such as acetone) and phenols.

Any of the above-mentioned catalysts may, of course, be used as mixtures.

The catalysts can be premixed with the diisocyanate component, the polyether diol component, or, less preferably because of potential side reactions, the brominated chain extender, or they can be added separately. Catalysts, if used at all, are generally used in a quantity ranging from about 0.001 to about 1% by weight of the total reaction mixture, although about 0.01 to 0.1 percent by weight is generally preferred.

Auxiliary agents and additives other than catalysts may optionally also be used in the preparation of the compounds of the invention. Suitable auxiliary agents and additives may include, for example, internal mold release agents, processing aids, antioxidants, plasticizers, and fungistatic or bacteriostatic substances. The auxiliaries and additives can be used in quantities normally used for such materials. For example, when using the preferred antioxidants and processing aids, it is generally preferred, although not critical, to use about 0.1 to 1.5 percent by weight of the antioxidant and about 0.15 to 1.0 percent by weight of the processing aid.

The polyurethane compositions are prepared by any of several methods known in the art. The polyurethane-forming reaction components may be reacted by the known one-stage process, by the prepolymer process, or by the semi-prepolymer process. Machines, such as those described in U.S. Pat. No. 2,764,565, may be used in many of these processes. Particulars of the processing machines which may also be used to produce polyurethanes according to the invention may be found in Kunststoff-Handbuch, Vol. VII, Vieweg and Hochtlen, Carl-Hanser-Verlag, Munich 1966, pages 121 to 205.

In the one-stage (or "one-shot") method, the isocyanate-reactive components, including the polyester diol and the isocyanate-reactive bromine-containing compound, as well as any additives and auxiliaries, are combined and thoroughly blended in a premix. The cycloaliphatic diisocyanate is then mixed with the premix. The isocyanate-reactive and diisocyanate components can be mixed batchwise or in a processing machine and poured into a mold or can be introduced separately into a mold where the polymerization reaction takes place. External release agents, such as silicone oils, are often used during the molding process. It is, however, also possible to use so-called "internal release agents", optionally in admixture with external release agents, as described, for example, in German Offenlegungsschriften 2,121,670 and 2,307,589.

In the prepolymer method, a prepolymer is formed by reacting the diisocyanate with a portion of the polyester diol or a blend of the polyester diol with the bromine-containing compound. The prepolymer is then allowed to react with the balance of the isocyanate-reactive components to form a polyurethane composition of the invention.

The semiprepolymer method is similar to the prepolymer method except that a portion of the cycloalkyl diisocyanate remains unreacted. That is, the isocyanate component is a mixture of unreacted diisocyanate and true prepolymer. As in the prepolymer method, the semiprepolymer is then allowed to react with the balance of the isocyanate-reactive components to form a polyurethane.

Regardless of the method used, the reactive components are used in quantities such that the isocyanate index is from about 0.95 to about 1.2 (preferably 0.95 to 1.1). By "isocyanate index" is meant the quotient of the number of isocyanate groups divided by the number of isocyanate-reactive groups.

The radiopaque thermoplastic polyurethanes of the invention may be processed by melt processing techniques known in the art. For example, slabs of the polyurethane can be chopped into strips and further granulated into smaller pieces. After being dried in a vacuum oven, the resultant ground material can be melt extruded on a single screw or twin screw extruder into strands that are then pelletized. In contrast to aromatic polyisocyanate-based thermoplastic polyurethanes that are melt extruded at temperatures of about 175 C. to 400 C., polyurethanes of the present invention can be successfully melt extruded at much lower temperatures, for example, as low as about 90 C. (preferably 90 C. to 200 C.). The pelletized material may then be subjected to a second melt processing step to produce the desired articles. Thus, the polyurethanes of the invention may be extruded into tubes and catheters of various internal and external diameters and gauges. Furthermore, they may be again extruded, co-extruded with other polymers, or injection molded into virtually any desired shape.

The following examples further illustrate details for the preparation of the compositions of this invention. The invention, which is set forth in the foregoing disclosure, is not to be limited either in spirit or scope by these examples. Those skilled in the art will readily understand that known variations of the conditions and processes of the following preparative procedures can be used to prepare these compositions. Unless otherwise noted, all temperatures are degrees Celsius and all percentages are percentages by weight.

EXAMPLES Starting materials

Isocyanate--dicyclohexylmethane-4,4'-diisocyanate (available as DESMODUR W from Miles Inc.)

Polyol--a polybutylene adipate having a molecular weight of from 2000 to 4000 (available as DESMOPHEN 2502 from Miles Inc.)

Extender--tetrabromobisphenol A bis(2-hydroxyethyl ether) (available as BA-50P from Great Lakes Chemical Corporation)

Catalyst--dibutyltin dilaurate (available as DABCO T-12 from Air Products and Chemicals, Inc.)

Antioxidant--octadecyl 3,5-di-t-butyl-4-hydroxycinnamate (available as IRGONOX 1076 from Ciba-Geigy)

Processing aid--N,N-dioleoylethylenediamine (available as GLYCOLUBE VL from Lonza)

General Procedure

Each example was carried out using 0.02 wt. % catalyst, 1.0 wt.% antioxidant, and 0.55 wt. % processing aid based on the total reaction mixture. Proportions of the reactive isocyanate, polyol, and extender components (given as equivalent ratios relative to the isocyanate), as well as hard segment and bromine content of the resultant polyurethanes, are listed in Table 1.

The polyester polyol, bromine-containing chain extender, antioxidant, and processing aid were mixed in a stainless steel reactor, which was then placed in a convection oven at a temperature of about 80-130 C. until a molten liquid mixture was obtained (typically about two hours). The isocyanate and catalyst were added to a dry container and warmed in an oven at about 60 C. until used.

The molten polyol component was then vigorously stirred with a high speed homogenizer and maintained at a temperature of about 100 C. The isocyanate component was then added in one portion to the reactor. The resultant mixture was stirred for about 15 seconds, after which it was poured into a teflon-lined tray and post-cured in an infrared oven for five minutes at 120 C. and an additional five minutes at 90 C. The molded material was removed from the oven and allowed to cool to 25 C.

The resultant slab was granulated and dried in a vacuum oven at a temperature below 60 C. for about 16 hours. The dried granulate was then processed using a single-screw extruder at temperatures of 120-180 C. to give optically transparent strands of polyurethane product. The temperatures used for extrusion of the Examples are listed in Table 1.

The strands were then pelletized. The pelletized polyurethane was injection molded at about the same temperatures as used for the extrusions to form plaques having a thickness of 3.175 mm. Physical properties of the polyurethane plaques are listed in Table 2.

              TABLE 1______________________________________Compositions and extrusion temperatures used forpolyurethanes of the invention              Example              1     2______________________________________Polyol (equiv. ratio.sup.(1))                0.105   0.184Extender (equiv. ratio.sup.(2))                0.86    0.78Hard segment (wt. %) 65.33   67.56Bromine content (wt. %)                22.10   22.10Extrusion temperature (C.)                149-171 154-169______________________________________ .sup.(1) Equivalent ratio of polyol to isocyanate .sup.(2) Equivalent ratio of extender to isocyanate

              TABLE 2______________________________________Physical properties of polyurethane plaques of the invention            Example            1     2______________________________________Elongation (MPa)   2.28    2.31Tensile strength   21.31   32.55(break) (MPa)Modulus (MPa)At 100%            13.86   22.78At 200%            15.17   23.45At 300%            19.21   29.99Flex modulus (MPa)Dry                273.48  784.67Wet (24 hr)        156.88  386.72Shore D hardness   65      75______________________________________
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2212334 *Aug 15, 1936Aug 20, 1940Mueller & Co VCatheter
US2857915 *Apr 2, 1956Oct 28, 1958Sheridan David SX-ray catheter
US3336918 *Dec 24, 1962Aug 22, 1967Us Catheter & Instr CorpRadiopaque, urethane-coated catheter and method for coating same
US3529633 *Oct 23, 1967Sep 22, 1970Bard Inc C RX-ray opaque tubing having a transparent stripe
US3605750 *Apr 7, 1969Sep 20, 1971David S SheridanX-ray tip catheter
US3608555 *Dec 31, 1968Sep 28, 1971Chemplast IncRadio opaque and optically transparent tubing
US3618614 *May 6, 1969Nov 9, 1971Scient Tube Products IncNontoxic radiopaque multiwall medical-surgical tubings
US3645955 *Mar 18, 1970Feb 29, 1972Scient Tube Products IncPlasticized radiopaque vinyl resin compositions
US3749134 *Feb 2, 1972Jul 31, 1973Sunlite Plastics IncRadiographically opaque plastic tubing
US3901829 *Jul 19, 1973Aug 26, 1975Sunlite Plastics IncMethod of making radiographically opaque plastic tubing
US4027659 *Nov 21, 1975Jun 7, 1977Krandex CorporationRadiographic opaque and conductive stripped medical tubes
US4105732 *Feb 25, 1977Aug 8, 1978Krandex Corp.Radiographic opaque and conductive striped medical tubes
US4182787 *Jun 19, 1978Jan 8, 1980General Electric CompanyPolysiloxane-polycarbonate terpolymer
US4282876 *Dec 28, 1979Aug 11, 1981Flynn Vincent JMedical-surgical catheters
US4722344 *May 23, 1986Feb 2, 1988Critikon, Inc.Radiopaque polyurethanes and catheters formed therefrom
US4939007 *Mar 7, 1988Jul 3, 1990Becton, Dickinson And CompanyArticle having a hemocompatible surface
US5177170 *Jul 2, 1992Jan 5, 1993Miles Inc.From Cycloaliphatic Diisocyanates, Polyether Diols, and Tetrabromodipentaerythritol
Non-Patent Citations
Reference
1 *Y. Delaviz et al, Polymer Preprints (Polymer Division, Am. Chem. Soc.), 30, 215 216 (1989).
2Y. Delaviz et al, Polymer Preprints (Polymer Division, Am. Chem. Soc.), 30, 215-216 (1989).
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US5963373 *Sep 10, 1996Oct 5, 1999Nippon Arc Co., Ltd.Primer composition
US5980564 *Aug 1, 1997Nov 9, 1999Schneider (Usa) Inc.Bioabsorbable implantable endoprosthesis with reservoir
US6174330Aug 1, 1997Jan 16, 2001Schneider (Usa) IncBioabsorbable marker having radiopaque constituents
US6200338Dec 31, 1998Mar 13, 2001Ethicon, Inc.Enhanced radiopacity of peripheral and central catheter tubing
US6245103Aug 1, 1997Jun 12, 2001Schneider (Usa) IncBioabsorbable self-expanding stent
US6251135Mar 8, 1999Jun 26, 2001Schneider (Usa) IncRadiopaque marker system and method of use
US6340367Aug 1, 1997Jan 22, 2002Boston Scientific Scimed, Inc.Radiopaque markers and methods of using the same
US6623823Dec 31, 1998Sep 23, 2003Ethicon, Inc.Optically transparent polyurethane catheter with bromine containing polyurethane radiopaque coating
US6626939Dec 18, 1997Sep 30, 2003Boston Scientific Scimed, Inc.Stent-graft with bioabsorbable structural support
US7108716Sep 30, 2003Sep 19, 2006Schneider (Usa) Inc.Stent-graft with bioabsorbable structural support
US7360504Mar 17, 2003Apr 22, 2008T.F.H. Publications, Inc.Radiopaque animal chew
US7452929Sep 13, 2007Nov 18, 2008T.F.H. Publications, Inc.comprise a polymer that is inherently radiopaque or a polymer that has been made radiopaque by the addition of an additive that provides radiopaque characteristics
US7553325Aug 6, 2003Jun 30, 2009Boston Scientific Scimed, Inc.Bioabsorbable marker having radiopaque constituents
US7699887Aug 2, 2006Apr 20, 2010Boston Scientific Scimed, Inc.Stent-graft with bioabsorbable structural support
US7758631Nov 25, 2003Jul 20, 2010Boston Scientific Scimed, Inc.Bioabsorbable endoprosthesis having elongate axial reservoir for by-product collection
US7780875Jan 13, 2006Aug 24, 2010Cinvention AgComposite materials containing carbon nanoparticles
US7858078Dec 6, 2006Dec 28, 2010Tyco Healthcare Group LpBioabsorbable surgical composition
US7910129Dec 6, 2006Mar 22, 2011Tyco Healthcare Group LpCarbodiimide crosslinking of functionalized polyethylene glycols
US7947263Dec 6, 2006May 24, 2011Tyco Healthcare Group LpBiocompatible surgical compositions
US7998466Dec 6, 2006Aug 16, 2011Tyco Healthcare Group LpBiocompatible tissue sealants and adhesives
US8044234May 5, 2005Oct 25, 2011Tyco Healthcare Group LpBioabsorbable surgical composition
US8288477Dec 6, 2006Oct 16, 2012Tyco Healthcare Group LpBioabsorbable compounds and compositions containing them
US8357361Nov 17, 2010Jan 22, 2013Covidien LpBioabsorbable surgical composition
US8449714Dec 8, 2006May 28, 2013Covidien LpBiocompatible surgical compositions
CN101392048BSep 27, 2008Apr 27, 2011清华大学Method for preparing developing polyurethane
EP1016423A1 *Dec 23, 1999Jul 5, 2000Ethicon Inc.Radiopaque polymer blend
EP2348052A2Sep 17, 2008Jul 27, 2011The Regents of The University of CaliforniaInternalizing human monoclonal antibodies targeting prostate cancer cells in situ
WO2012125582A1Mar 12, 2012Sep 20, 2012Board Of Regents Of The University Of NebraskaBiomarker for coronary artery disease
Classifications
U.S. Classification528/85, 528/271, 528/86, 528/76, 528/77, 528/272, 528/299
International ClassificationC08G18/38, A61L29/06, C08G18/75, C08G18/66
Cooperative ClassificationA61L29/06, C08G18/75, C08G18/6633, C08G18/381
European ClassificationA61L29/06, C08G18/38C2D5, C08G18/75, C08G18/66M
Legal Events
DateCodeEventDescription
Feb 19, 2006FPAYFee payment
Year of fee payment: 12
Mar 1, 2002FPAYFee payment
Year of fee payment: 8
Feb 17, 1998FPAYFee payment
Year of fee payment: 4
Jan 13, 1993ASAssignment
Owner name: MILES INC., PENNSYLVANIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:SARPESHKAR, ASHOK M.;MARKUSCH, PETER H.;REEL/FRAME:006400/0949
Effective date: 19930107